Doxytetracycline en es it fr

Doxytetracycline Brand names, Doxytetracycline Analogs

Doxytetracycline Brand Names Mixture

  • No information avaliable

Doxytetracycline Chemical_Formula


Doxytetracycline RX_link

Doxytetracycline fda sheet

Doxytetracycline FDA

Doxytetracycline msds (material safety sheet)

Doxytetracycline MSDS

Doxytetracycline Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Doxytetracycline Molecular Weight

444.435 g/mol

Doxytetracycline Melting Point

201 oC

Doxytetracycline H2O Solubility

630 mg/L

Doxytetracycline State


Doxytetracycline LogP


Doxytetracycline Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Doxytetracycline Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Doxytetracycline Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Doxytetracycline Absorption

completely absorbed after oral administration

Doxytetracycline side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Doxytetracycline Patient Information

Doxytetracycline Organisms Affected

Enteric bacteria and other eubacteria